BRAF and skin neoplasm: There are some molecular and immunostaining-based studies, both in in vitro and in vivo settings, with in- consistent results regarding the prevalence, clinical implications and correlation with pathologic and prognostic variables of BRAF V600E in skin neoplasms 20 (13).